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The regulatory mechanism of hepatic palmitate oxidation into ketone bodies by c-kinase has been studied 
in isolated hepatocytes. Glucagon and epinephrine stimulated [U-“+C]palmitate oxidation to ketone bodies 
by 60 and 25% as early as at 1 h. The stimulatory effects were almost totally prevented by the simultaneous 
presence of vasopressin, phorbol 1Ztetradecanoate 13-acetate (TPA), or diacylglycerol (1-oleoyl-Zacetyl- 
glycerol). When hepatocytes were treated with glucagon or epinephrine, carnitine palmitoyltransferase 
(CPT), a key regulatory enzyme of palmitate oxidation, was activated. This hormone-induced activation 
of CPT was not observed in the presence of TPA. These observations uggest hat c-kinase inhibits gluca- 
gon- or epinephrine-stimulated palmitate oxidation to ketone bodies, and that this inhibition may be medi- 
ated through a covalent modification of CPT. 
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1. INTRODUCTION 
Hepatic ketogenesis has been reported to be 
stimulated by glucagon and catecholamines [ 1,2]. 
We have recently proposed a new regulatory 
mechanism by covalent modification of carnitine 
palmitoyltransferase (CPT) [3,4]. Glucagon prob- 
ably stimulates ketogenesis by the activation of 
CAMP-dependent protein kinase (A-kinase) [3] 
while epinephrine or norepinephrine may similarly 
stimulate it through cui-adrenergic receptors and 
probably via Ca-calmodulin-dependent protein 
kinase [2]. Recently, a third protein kinase (c- 
kinase) has been discovered by Nishizuka, and new 
regulatory roles in hepatic glucose metabolism 
have been suggested [5]. Hems and Whitton [6] 
have reported that vasopressin, which activates c- 
kinase, stimulates hepatic glycogenolysis through 
activation of phosphorylase [7], the data sug- 
gesting an involvement of c-kinase. In contrast, 
vasopressin seems to inhibit glucagon-stimulated 
ketogenesis in isolated hepatocytes [7]. The effect 
of vasopressin on catecholamine-stimulated 
ketogenesis has not yet been studied. 
Here, the effect of vasopressin, TPA and 
diacylglycerol (a second messenger of the c-kinase 
system) on hepatic ketogenesis and CPT activity 
has been investigated in attempting to show a 
possible interaction of 3 protein kinases (A-kinase, 
Ca-calmodulin-dependent protein kinase, c- 
kinase). 
2. MATERIALS AND METHODS 
2.1. Materials 
[U-14C]Palmitate (500 mCi/mmol) and aqueous 
counting scintillant (ACS-II) were obtained from 
the Research Centre, Amersham, England. Col- 
lagenase class 2 (133 U/mg) was obtained from 
Worthington, Freehold, NJ. Bovine serum 
albumin (fraction V), essentially FFA-free bovine 
albumin, vasopressin and TPA were purchased 
from Sigma, St. Louis, MO. Diacylglycerol 
(1 -oleoyl-2-acetylglycerol) was kindly provided by 
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Professor Y. Nishizuka, Kobe University, Kobe, 
Japan. Insulin-free glucagon was a gift from Dr 
J.A. Galloway, Eli Lilly Research Laboratories, 
Indianapolis, IN. TPA was freshly dissolved in 
DMSO at 5 mg/ml and diacylglycerol in DMSO at 
10 mg/ml so that the DMSO concentration in the 
assay was always CO. 1%. Each control also con- 
tained the corresponding amount of DMSO. Other 
reagents were analytical grade and were obtained 
from Nakarai Chemicals, Kyoto, Japan. 
2.2. Isolation of hepatocytes 
Male Sprague-Dawley rats weighing 250-300 g 
each were fed ad libitum on regular laboratory 
chow (CLEA-CEII, CLEA Japan, Osaka) until the 
time of the experiment. Rats were anesthetized 
with an intraperitoneal injection of sodium pen- 
tobarbital (5 mg/lOO g). 
Hepatocytes were isolated by a modification of 
Seglen’s method as described [2,8]. After being 
washed twice by centrifugation, cells were 
suspended in Krebs-Ringer-bicarbonate buffer at a 
concentration of 6-8 x lo6 cells per ml (10.3 f 
1.89 mg protein/ml, mean + SD). The isolated 
hepatocytes were more than 95% viable as judged 
by trypan blue exclusion. Protein was determined 
using the Bio-Rad assay after being solubilized in 
0.1% SDS. 
2.3. Study of palmitate oxidation and ketogenesis 
The assay system consisted of 0.3 mM 
[U-14C]palmitate bound to 0.3 mM albumin, 
100 mg/dl glucose, and 11.5 mM Hepes in Krebs- 
Ringer-phosphate buffer (pH 7.4) in a total 
volume of 2.0 ml in 25 ml siliconized Erlenmeyer 
flasks filled with 95% 02 and 5% CO2 (v/v). The 
reaction was started by the addition of hepatocytes 
(300-400 x lo4 cells corresponding to 4.2-5.6 mg 
protein). The flasks were sealed with rubber stop- 
pers with hanging small caps and incubated for 1 h 
at 37°C. At the end of incubation, 1 ml of 10% 
perchloric acid (PCA) was added to the main flask, 
and the liberated CO2 was absorbed in 0.3 ml 
scintilamine-OH which was placed in the small cap 
for 1 h. This mixture was centrifuged at 700 x g 
for 10 min. i4C counts of 0.5 ml of the superna- 
tant and 0.3 ml of scintilamine-OH were measured 
respectively by mixing with 5 ml ACS-II. The 
radioactivity measured in the acid-soluble fraction 
represents the P-oxidation products and almost ex- 
elusively ketone body formation as reported 
W,91. 
Glucagon and epinephrine stimulated 
ketogenesis in a dose-dependent manner and the 
dose which exhibited maximal response was used 
in this experiment. [U-14C]Palmitate oxidation to 
acid-soluble products (mainly 14C-ketone bodies) 
and 14C02 for 1 h were 12.2 f 0.19 and 2.4 f 
0.33 nmol palmitate/mg protein, respectively. 
Thus, under the above assay conditions, the ma- 
jority of the oxidation products were ketone bodies 
and only 20% was COZ. Therefore, in most ex- 
periments, [U-‘4C]palmitate oxidation was 
measured by determining acid-soluble ketone body 
production. 
2.4. Determination of CPT activity 
Isolated hepatocytes were incubated with hor- 
mones for 20 min at 37°C as described above 
without labelled palmitate. Cells were centrifuged 
at 700 x g for 3 min. 0.5 ml buffer containing 
0.25 M sucrose, 5 mM Hepes, 1 mM NaF, 
0.1 mM EDTA and 0.5% Triton X-100 was added 
to the cell precipitate, and the mixture frozen at 
-20°C. The lysed cell suspension was then cen- 
trifuged at 10’ x g for 60 min. CPT activity was 
determined using an aliquot of the supernatant by 
measuring carnitine-dependent CoA release from 
palmitoyl-CoA using a Shimazu UV300 dual- 
wavelength spectrophotometer [3]. Activity was 
determined at low (20pM) and high (80pM) con- 
centrations of palmitoylCoA. 
3. RESULTS 
3.1. Effect of glucagon, epinephrine and c-kinase 
stimulants on hepatic ketogenesis 
Maximal stimulation of ketogenesis was observ- 
ed at 200 ng/ml glucagon and 1 fig/ml 
epinephrine, amounting to 60 and 25% over con- 
trol, respectively (table 1). Vasopressin (10 ng/ml), 
TPA (100 nM and 5 PM) or diacylglycerol 
(10 pg/ml) alone did not affect [U-‘4C]palmitate 
oxidation. 
3.2. Effect of c-kinase stimulants on glucagon- 
or epinephrine-stimulated ketogenesis 
Fig. 1 shows dose-responsive inhibition of 
glucagon-stimulated ketogenesis and CO2 produc- 
tion by TPA. TPA totally inhibited the glucagon- 
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Table 1 
Effect of glucagon, epinephrine and c-kinase stimulants 
on ketogenesis in freshly isolated hepatocytes 
Additions No. of [U-‘4C]Palmitate 
experiments oxidized into acid- 
soluble fraction (nmol 
palmitate/mg 
protein per h) 
Control 
Glucagon 
23 12.2 * 0.19 
(200 ng/ml) 
Epinephrine 
9 19.0 + 0.14a 
(1 pg/ml) 
Vasopressin 
17 15.3 & 0.45” 
(10 ng/ml) 
TPA (100 nmol/l) 
TPA (5 PM) 
Diacylglycerol 
16 11.9 + 0.20 
5 11.6 + 0.32 
10 11.4 + 0.21 
(10 pg/ml) 6 12.0 + 0.10 
a p < 0.001 vs control 
Each value is the mean * SE. Results were evaluated 
using Student’s t-test. Freshly isolated hepatocytes were 
incubated with 0.3 mmol/l [U-‘4C]palmitate bound to 
0.3 mmol/l albumin in the presence or absence of the 
indicated compounds. The reaction was terminated with 
3% PCA and the radioactivity determined in the 
supernatant as in [4] 
induced effects at 1O-8-1O-5 M. In epinephrine- 
stimulated ketogenesis and CO2 production, TPA 
also shows inhibition in a dose-responsive manner 
(fig.2). 
In addition to TPA (100 nM and 5 PM), 
vasopressin (10 ng/ml), and diacylglycerol 
(10 pg/ml) almost totally prevented the glucagon- 
induced stimulation of ketogenesis (fig.3). Similar- 
ly, vasopressin, diacylglycerol, and TPA reversed 
the epinephrine-induced stimulation of hepatic 
ketogenesis. 
3.3. Effects of glucagon, epinephrine, and TPA 
on CPT activity 
Mean CPT activity at 20 and 80pM palmitoyl- 
CoA for the control was 5.8 + 0.6 and 11.9 f 
1.4 nmol/mg protein per min (mean + SE, n = 5), 
respectively (table 2). Glucagon (200 ng/ml) treat- 
ment for 20 min enhanced CPT activity by 78% in 
lysed cell supernatant at 20pM palmitoyl-CoA, 
300 
200 
100 
Ghcagod200 no/ml) +TPA 
ap I 
“(1,“:: 
-LoQCTPAI mol/l 
Fig. 1. Inhibitory effect of TPA on glucagon-stimulated 
palmitate oxidation. Hepatocytes were incubated for 1 h 
with 0.3 mM [U-‘4C]palmitate bound to 0.3 mM 
albumin in the presence of glucagon (200 ng/ml) and 
various concentrations of TPA. Each value is the mean 
of 2 experiments. Percent oxidation into ketone bodies 
(0) and CO2 production (0) over control are shown on 
the ordinate. Mean value of control (n = 8) was 12.2 ? 
0.19 and 2.4 f 0.33 (nmol palmitate/mg protein) for the 
rate of ketone body and CO2 production, respectively. 
(- ) Experiments without TPA. 
Epiiphrii(l~/ml)+TPA 
Y 
150 
-Lo~tTl'Al molll 
Fig.2. Inhibitory effect of TPA on epinephrine- 
stimulated palmitate oxidation. Hepatocytes were 
incubated under the same conditions as in fig.1. 
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Fig.3. Effect of c-kinase stimulants of glucagon- or epinephrine-stimulated ketogenesis in isolated hepatocytes. 
Hepatocytes were incubated with 0.3 mM [U-‘4C]palmitate bound to 0.3 mM albumin in the presence of glucagon 
(200 ng/ml) (G), glucagon (200 ng/ml) and TPA (100 nM) (G + Tr), glucagon (200 ng/ml) and TPA (5 PM) (G + Tn), 
glucagon (200 ng/ml) and vasopressin (10 ng/ml) (G + V), or glucagon (200 ng/ml) and diacylglycerol (10 #g/ml) 
(G + D) (left panel). The same experiments were performed with epinephrine (1 fig/ml) (E), epinephrine (1 pg/ml) and 
TPA (100 nM) (E + Tr), epinephrine (1 pg/ml) and TPA (5 PM) (E + Tn), epinephrine (1 pg/ml) and vasopressin 
(10 ng/ml) (E + V), or epinephrine (1 pg/ml) and diacylglycerol(l0 pg/ml) (E + D) (right panel). Each value is the mean 
f SE. Results were evaluated using Student’s t-test. * p < 0.005 vs glucagon. ** p < 0.025 vs epinephrine. *** p < 
0.05 vs epinephrine. 
and by 68% at 80 ,uM palmitoyl-CoA over control. 
Epinephrine (1 pg/ml) treatment enhanced CPT 
activity by 79% at 20 PM palmitoyl-CoA and by 
69% at 80 pM palmitoyl-CoA over control. Addi- 
tion of TPA (5 pM) to the incubation mixture 
reversed the activation of CPT by both glucagon 
and epinephrine. 
4. DISCUSSION 
The present studies demonstrate that 
vasopressin (10 ng/ml), TPA (100 nM) and 
diacylglycerol(l0 pg/ml) all inhibited glucagon- as 
well as epinephrine-stimulated hepatic ketogenesis. 
Vasopressin, TPA, or diacylglycerol alone showed 
no effect on basal ketogenesis. Furthermore, TPA 
inhibited the increase in CPT activity induced by 
glucagon or epinephrine in cell lysates, suggesting 
that TPA may regulate CPT activity through 
possible involvement of c-kinase. c-Kinase, which 
is activated by Ca*+, phospholipid and 
diacylglycerol, is widely present in various tissues 
[lo]. In the liver, much attention has been paid to 
the possible role of c-kinase in the regulation of 
glucose metabolism. In isolated rat hepatocytes, 
TPA antagonizes both glucagon-stimulated 
adenylate cyclase activity [ 1 l] and the epinephrine- 
induced stimulation of glycogenolysis [ 121. Re- 
garding ketogenesis, inhibition of glucagon- 
stimulated ketogenesis by vasopressin has been 
reported by Williamson et al. [8], but the precise 
mechanism remains unclear. Vasopressin generates 
two intracellular messengers, diacylglycerol and 
Ca*+ [ 131. Recently, Morgan et al. [ 141 reported 
that vasopressin inhibited glucagon-induced 
CAMP accumulation, which was not dependent on 
cellular Ca*+ mobilization. Therefore the c-kinase 
system might involve direct inhibition of adenylate 
cyclase. Thus, c-kinase stimulants (TPA, 
vasopressin, diacylglycerol) may inhibit glucagon- 
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Table 2 
Early effect of glucagon, epinephrine and TPA on CPT 
activity in lysed hepatocytes 
Additions CPT activity (nmol/mg 
protein per min) 
Palmitoyl-CoA Palmitoyl-CoA 
(20 /mot/l) (80 pmol/l) 
Control 5.8 f 0.6 11.9 f 1.4 
Glucagon (200 ng/ml) 10.3 * 1.3a 20.6 f l.Sa 
Epinephrine (1 pg/ml) 10.4 + 0.9” 20.1 If 2.2a 
TPA (5 PM) 6.2 + 1.2 11.0 + 2.7 
Glucagon (200 ng/ml) 
+ TPA (5 PM) 7.6 + 0.6b 12.3 + 0.3b 
Epinephrine (1 fig/ml) 
+ TPA (5 ,uM) 6.0 f 0.9’ 10.1 + 0.6’ 
a p < 0.025 vs control 
b p < 0.025 vs glucagon 
’ p < 0.025 vs epinephrine 
Each value is the mean f SE of 5 experiments. Results 
were evaluated by the use of paired f-test. Freshly 
isolated hepatocytes were incubated with or without the 
indicated compounds for 20 min. Cells were centrifuged 
down, lysed with 0.5% Triton X-100, then centrifuged at 
1 X 10’ x g for 60 min. CPT activity was determined 
using an aliquot of supernatant 
stimulated ketogenesis either through direct inhibi- 
tion of adenylate cyclase or via the inhibition of 
CPT. 
Recently, Cooper et al. [13] have reported that 
pretreatment with phorbol ester or synthetic 
diacylglycerol inhibits phenylephrine-induced 
elevation of cytosolic Ca2+ concentration in 
isolated hepatocytes. This observation is consistent 
with the hypothesis that c-kinase modulates CPT 
activity through the inhibition of Ca2+ mobiliza- 
tion. However, there is still a possibility that dif- 
ferent hormones display site-specific phosphoryla- 
tion as a regulatory mechanism of CPT activity 
14,151. 
As for the activation of ketogenesis by glucagon, 
two mechanisms have been proposed. McGarry et 
al. [16] reported that glucagon decreased acetyl- 
CoA carboxylase activity and that the decreased 
formation of malonyl-CoA levels might stimulate 
hepatic ketogenesis. Recently, a new regulatory 
mechanism of ketogenesis has been proposed from 
our laboratory; glucagon stimulates hepatic 
ketogenesis via phosphorylation of CPT through 
CAMP-dependent protein kinase [4]. The increased 
CPT activity was mainly attributed to the in- 
creased affinity for palmitoyl-CoA rather than the 
enhancement of maximal velocity (V,,). This was 
confirmed at the two different concentrations of 
palmitoyl-CoA (20 and 80pM) in this study. 
The stimulatory effect of catecholamine on 
hepatic palmitate oxidation was reversed by 
prazosine (cur-blocker) and W7 [IV-(6aminohexyl)- 
5-chloro-1-naphthalenesulfonamide; a calmodulin 
antagonist] but not by yohimbine @z-blocker) 
[ 171. Therefore, epinephrine-stimulated palmitate 
oxidation is most likely mediated by cur-adrenergic 
receptors through the activation of Ca-calmodulin- 
dependent protein kinase. Oberhaensli et al. [ 181 
have postulated that stimulation of ketogenesis by 
norepinephrine may be due to the decreased for- 
mation of malonyl-CoA, but our data suggest hat 
epinephrine stimulates CPT possibly through 
phosphorylation as in the case of stimulation with 
glucagon, although direct evidence for the phos- 
phorylation of CPT has not been obtained. 
Since comparable changes of CPT activity in 
relation to palmitate oxidation were observed, 
direct activation of CPT by A-kinase or Ca- 
calmodulin-dependent protein kinase is thought to 
take place with glucagon and epinephrine, respec- 
tively, and c-kinase seems to antagonize the 
stimulation of hepatic ketogenesis timulated by 
glucagon and epinephrine at the level of carnitine 
palmitoyltransferase. 
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